Naslov
The activity of anidulafungin against clinical isolates of Candida spp.

Autori
Bubonja Šonje, Marina ; Pinjuh. Goran ; Abram, Maja

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni

Izvornik
CroCMID 2016, knjiga sažetaka / HLZ, HDKM, HDIB - Zagreb, 2016, 147-148

Skup
CroCMID 2016

Mjesto i datum
Poreč, Hrvatska, 20.10.2016. - 23.10.2016

Vrsta sudjelovanja
Poster

Vrsta recenzije
Domaća recenzija

Ključne riječi
candida; anidulafungin

Sažetak
Anidulafungin belongs to a unique class of new antifungals known as echinocandins. Resistance to anidulafungin is emerging, especially in non-albicans Candida isolates. The susceptibility of 80 clinical Candida isolates to anidulafungin and fluconazole was determined by E-test on RPMI agar with 2% glucose using EUCAST breakpoints. Clinical isolates from different clinical specimens were collected in first quarter of 2016. Colection included 31 C. albicans, while most non-albicans isolates belonged to C. glabrata, C. parapsilosis, C. tropicalis and C. krusei species. Almost all C. albicans strains were susceptible to fluconazole and anidulafungin (30/31), while majority of non-albicans isolates were resistant to fluconazole (30/49). Resistance or decreased sensitivity to anidulafungin was detected in 7 non-albicans strains, particulary in C. parapsilosis. The MIC50 and the MIC90 values for anidulafungin for non-albicans isolates were 0.012 mg/l or 0.906 mg/l, respectively.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

Napomena
Supported by "Molecular mechanisms of bacterial pathogenesis and response to stress" (M.A. Grant No. 13.06.1.1.07. from the University of Rijeka, Croatia)

POVEZANOST RADA